A Critical Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma and CAR T-cell Therapy
By Annenberg Center for Health Sciences
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Annenberg Center for Health Sciences
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 4
Description
In this activity, Jeremy Abramson, MD, highlights the significant disease burden of B-cell lymphomas, as well as the latest advances in therapeutics, and practical strategies for integrating novel therapies into practice through patient selection and supportive care management.
| Episode | Date |
|---|---|
|
Principles of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Large B-Cell Lymphoma: Patient Selection Strategies
|
Jun 09, 2022 |
|
Treatment of Large B-Cell Lymphoma: MOA and Clinical Efficacy Data of Novel Therapies
|
Jun 09, 2022 |
|
Disease Burden and Overview of Large B-Cell Lymphomas
|
Jun 09, 2022 |
|
Management of Adverse Effects Associated With Novel Therapies
|
Jun 09, 2022 |